Lv1
40 积分 2022-07-11 加入
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
7天前
已完结
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
28天前
已完结
A First-in-Class JAK/ROCK Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic GVHD
1个月前
已关闭
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial
4个月前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody-drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
4个月前
已完结
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
4个月前
已完结
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
4个月前
已完结
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
4个月前
已完结
Systemic therapy for advanced cervical cancer: Leveraging the historical threshold of overall survival
9个月前
已完结